Eric P. Palmer - Feb 13, 2024 Form 4 Insider Report for Cigna Group (CI)

Role
EVP, Enterprise Strategy and President & CEO, Evernorth Health Services
Signature
Matthew Arnold, attorney-in-fact
Stock symbol
CI
Transactions as of
Feb 13, 2024
Transactions value $
-$1,162,523
Form type
4
Date filed
2/15/2024, 05:30 PM
Previous filing
Feb 13, 2024
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Options Exercise $771K +5.17K +11.34% $149.14 50.7K Feb 13, 2024 Direct F1
transaction CI Common Stock, $.01 Par Value Sale -$2.07M -6.08K -11.99% $340.00 44.6K Feb 13, 2024 Direct F1
transaction CI Common Stock, $.01 Par Value Options Exercise $135K +905 +2.03% $149.14 45.6K Feb 14, 2024 Direct F1
transaction CI Common Stock, $.01 Par Value Gift $0 -200 -0.44% $0.00 45.4K Feb 15, 2024 Direct
transaction CI Common Stock, $.01 Par Value Gift $0 -312 -0.69% $0.00 45K Feb 15, 2024 Direct
transaction CI Common Stock, $.01 Par Value Gift $0 +312 +27.73% $0.00 1.44K Feb 15, 2024 By Trust
holding CI Common Stock, $.01 Par Value 245 Feb 13, 2024 By 401(k) F2
holding CI Common Stock, $.01 Par Value 41.1 Feb 13, 2024 By Spouse's 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -5.17K -85.1% $0.00 905 Feb 13, 2024 Common Stock, $.01 Par Value 5.17K $149.14 Direct F1
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -905 -100% $0.00* 0 Feb 14, 2024 Common Stock, $.01 Par Value 905 $149.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F2 Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

Remarks:

EVP, Enterprise Strategy and President & CEO, Evernorth Health Services